Delivery Order SPE2DB20D3103-SPE2DB24FP8C7

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,038.98 Firm Fixed Price Delivery Order is for the supply of 4,563,401,913 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.04 firm fixed-price delivery order is for the supply of 4,567,752,489 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, with a period of performance through April 1, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $24,742.17 firm-fixed price contract has a performance period through February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $4,129.02 firm-fixed-price delivery order is for the supply of 4,555,039,940 units of pantoprazole sodium delayed-release 40 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of 1,000 units of 40mg Pantoprazole Sodium Delayed-Release Tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,842.89, is a Firm Fixed Price Delivery Order with an ultimate completion date of June 11, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,005.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,517,461 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, with a completion date of November 22, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated with any set-aside requirements, indicating open...
This federal contract award is a $1,593.72 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, a medication used to treat gastroesophageal reflux disease and other conditions. The contract is a firm fixed-price, non-set-aside award with a completion date of July 1, 2025....
This federal contract award, valued at $1,432.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award, identified as SPE2DB22D3004|SPE2DB25FQQ74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,201,865 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, with a ceiling value of $1,185.84. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. The award date is May 9, 2025, and the ultimate...
This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMJWS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,146.87, is a Firm Fixed Price Delivery Order for the supply of 4567394234 ! PANTOPRAZOLE SOD DR 40 MG TAB 1000S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP8C7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,372.66 firm fixed-price delivery order contract is for the supply of 4,565,377,081 units of pantoprazole sodium delayed-release 40 mg tablets. The award has an ultimate completion date of August 8, 2024 and was not designated as a set-aside contract.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:45 AM